*** Welcome to piglix ***

Chloroquine

Chloroquine
Chloroquine.svg
Clinical data
Pronunciation /ˈklɔːrəkwɪn/
Trade names Aralen
AHFS/Drugs.com Monograph
License data
ATC code P01BA01 (WHO)
Legal status
Legal status
Pharmacokinetic data
Metabolism Liver
Biological half-life 1–2 months
Identifiers
CAS Number 54-05-7 YesY
PubChem (CID) 2719
IUPHAR/BPS 5535
DrugBank DB00608 YesY
ChemSpider 2618 YesY
UNII 886U3H6UFF YesY
KEGG D02366 YesY
ChEBI CHEBI:3638 YesY
ChEMBL CHEMBL76 YesY
NIAID ChemDB 000733
ECHA InfoCard 100.000.175
Chemical and physical data
Formula C18H26ClN3
Molar mass 319.872 g/mol
3D model (Jmol) Interactive image
  

Chloroquine is a medication used to prevent and to treat malaria in areas where malaria is known to be sensitive to its effects. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. It is also occasionally used for amebiasis that is occurring outside of the intestines, rheumatoid arthritis, and lupus erythematosus. It is taken by mouth.

Common side effects include muscle problems, loss of appetite, diarrhea, and skin rash. Serious side effects include problems with vision, muscle damage, seizures, and low blood cell levels. It appears to be safe for use during pregnancy but has not been well studied in this group of people. Chloroquine is a member of the drug class 4-aminoquinoline. It works against the asexual form of malaria inside the red blood cell.

Chloroquine was discovered in 1934 by Hans Andersag. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication. The wholesale cost in the developing world is about 0.04 USD. In the United States it costs about 5.30 USD per dose.

Chloroquine has long been used in the treatment or prevention of malaria from Plasmodium vivax, P. ovale, and P. malariae. After the malaria parasite Plasmodium falciparum started to develop widespread resistance to it.


...
Wikipedia

...